Stocks · Health care · Pharmaceutical Preparations

IONIS PHARMACEUTICALS INC

IONS Clue Score40
United States Fiscal year ends December CIK 0000874015 Results filed 29 Jul 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Eric Swayze
16 Oct 2026
EVP Research
Sell indirect
53
$43.54
$2.31K
Shannon L. Devers
16 Oct 2026
EVP, Chief Human Resources Ofc
Sell
1,357
$43.54
$59.08K
Joseph Baroldi
16 Apr 2026
EVP, Chief Business Officer
Sell
5,619
$74.56
$418.95K
Brian Birchler
16 Apr 2026
EVP, Corp and Development Ops
Sell
973
$75.04
$73.02K
Kyle Jenne
16 Apr 2026
EVP, Chf GL Pdt Str Ofcr
Sell
4,902
$75.17
$368.49K
Joseph Baroldi
30 Jan 2026
EVP, Chief Business Officer
Sell
5,296
$82.96
$439.36K
C Frank Bennett
30 Jan 2026
EVP, Chief Scientific Officer
Sell
5,885
$82.95
$488.14K
Brian Birchler
30 Jan 2026
EVP, Corp and Development Ops
Sell
6,179
$83.03
$513.05K
Elizabeth L Hougen
30 Jan 2026
EVP, Finance & CFO
Sell
6,988
$83.24
$581.70K
Brett P Monia
30 Jan 2026
Chief Executive Officer
Sell
62,970
$82.72
$5.21M
Patrick R. O'Neil
30 Jan 2026
EVP CLO & General Counsel
Sell
6,179
$83.53
$516.15K
Eugene Schneider
30 Jan 2026
EVP, Chf Clinical Develop Ofcr
Sell
6,179
$83.45
$515.63K
Eric Swayze
30 Jan 2026
EVP Research
Sell
6,179
$82.93
$512.45K
Joseph Baroldi
16 Jan 2026
EVP, Chief Business Officer
Sell indirect
1,149
$75.78
$87.07K
Joseph Baroldi
16 Jan 2026
EVP, Chief Business Officer
Sell
6,907
$75.75
$523.21K
C Frank Bennett
16 Jan 2026
EVP, Chief Scientific Officer
Sell
8,977
$75.15
$674.62K
Brian Birchler
16 Jan 2026
EVP, Corp and Development Ops
Sell
8,480
$75.11
$636.93K
Shannon L. Devers
16 Jan 2026
EVP, Chief Human Resources Ofc
Sell
8,353
$75.95
$634.41K
Elizabeth L Hougen
16 Jan 2026
EVP, Finance & CFO
Sell
12,922
$75.22
$971.99K
Kyle Jenne
16 Jan 2026
EVP, Chf GL Pdt Str Ofcr
Sell
1,823
$75.96
$138.48K
Holly B. Kordasiewicz
16 Jan 2026
EVP, Chief Development Officer
Sell
4,141
$75.66
$313.31K
Brett P Monia
16 Jan 2026
Chief Executive Officer
Sell
44,034
$74.82
$3.29M
Patrick R. O'Neil
16 Jan 2026
EVP CLO & General Counsel
Sell
9,191
$75.84
$697.05K
Eugene Schneider
16 Jan 2026
EVP, Chf Clinical Develop Ofcr
Sell
9,302
$75.59
$703.14K
Eric Swayze
16 Jan 2026
EVP Research
Sell indirect
49
$75.97
$3.72K
Eric Swayze
16 Jan 2026
EVP Research
Sell
9,884
$75.34
$744.66K

What was left out

Form 4 filings counted 101
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 66
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 1,631,784
History held since 10 Oct 2006